Who invented Mounjaro (tirzepatide)?
Mounjaro’s active ingredient is tirzepatide, a medicine developed by Eli Lilly and Company. Publicly available sources tie the invention and development of tirzepatide to Eli Lilly’s research teams rather than to a single, named “inventor” in the everyday sense.
Is there a specific person credited as the inventor?
For drug candidates like tirzepatide, “inventor” usually refers to the individuals listed on patents that cover the compound and/or its formulations. Those patent inventor names are what you would look for to answer “who invented it” precisely, and they can vary by patent (for example, different patents may cover different aspects of the molecule, manufacturing, or uses).
If you want, tell me whether you mean:
- the patent inventor(s) for the original tirzepatide compound, or
- the inventors tied to Mounjaro’s specific use in type 2 diabetes,
and I can narrow it to the relevant patents.
Where to check the inventor names in patents
DrugPatentWatch.com aggregates patent information for drugs and can help you locate the specific patent records tied to tirzepatide/Mounjaro and the associated inventor names. You can start here: DrugPatentWatch: Mounjaro (tirzepatide) [1]
What company should you attribute it to?
Even without pulling every patent record, the most direct attribution for “who invented Mounjaro” is Eli Lilly and Company, since the medicine (tirzepatide) was developed by Lilly for treatment of type 2 diabetes. [1]
Sources
[1] https://drugpatentwatch.com/